Back to Search Start Over

The Association of State Insurance Coverage Mandates with Assisted Reproductive Technology Care Discontinuation.

Authors :
Lee, Jacqueline C.
DeSantis, Carol E.
Yartel, Anthony K.
Kissin, Dmitry M.
Kawwass, Jennifer F.
Collaborative for Assisted Reproductive Technology Epidemiologic Research
Source :
American Journal of Obstetrics & Gynecology; Mar2023, Vol. 228 Issue 3, p315.e1-315.e14, 1p
Publication Year :
2023

Abstract

Insurance coverage for fertility services may reduce the financial burden of high-cost fertility care such as assisted reproductive technology and improve its utilization. Patients who exit care after failing to reach their reproductive goals report higher rates of mental health problems and a lower sense of well-being. It is important to understand the relationship between state-mandated insurance coverage for fertility services and assisted reproductive technology care discontinuation. This study aimed to assess whether state-mandated insurance coverage for fertility services is associated with lower rates of care discontinuation after an initial assisted reproductive technology cycle that did not result in a live birth. This is a retrospective, population-based cohort study using data from United States fertility clinics reporting to the National Assisted Reproductive Technology Surveillance System during 2016 and 2018. Patients who began their first autologous assisted reproductive technology cycle during 2016 and 2017 and did not have a live birth were included. We describe the rate of assisted reproductive technology care discontinuation (no additional cycle within 12 months of the previous cycle's date of failure). Multivariable analyses were conducted to evaluate factors independently associated with care discontinuation, including the scope of fertility services included in state coverage mandate at assisted reproductive technology cycle initiation that were as follows: comprehensive (≥3 assisted reproductive technology cycles), limited (1, 2, or an unspecified number of assisted reproductive technology cycles), mandate not including assisted reproductive technology, and no mandate. Among 91,324 patients who underwent their first autologous assisted reproductive technology cycle that did not result in live birth, 24,072 (26.4%) discontinued care. Compared with patients who lived in states with mandates for comprehensive assisted reproductive technology coverage, those in states with mandates for fertility services coverage that did not include assisted reproductive technology or states with no mandate were 46% (adjusted relative risk, 1.46; 95% confidence interval, 1.31–1.63) and 26% (adjusted relative risk, 1.26; 95% confidence interval, 1.15–1.39) more likely to discontinue care, respectively, after controlling for patient and cycle characteristics. Increasing patient age, distance from clinic ≥50 miles, previous live birth, fewer oocytes retrieved, and not having embryos cryopreserved were also associated with higher rates of discontinuation. Non-Hispanic Black, non-Hispanic Asian, and Hispanic patients had higher rates of care discontinuation than non-Hispanic White patients regardless of the existence or scope of state-mandated assisted reproductive technology coverage. Comprehensive state-mandated insurance coverage for assisted reproductive technology is associated with lower rates of assisted reproductive technology care discontinuation. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00029378
Volume :
228
Issue :
3
Database :
Supplemental Index
Journal :
American Journal of Obstetrics & Gynecology
Publication Type :
Academic Journal
Accession number :
161955094
Full Text :
https://doi.org/10.1016/j.ajog.2022.10.046